UFP TECHNOLOGIES INC · Surgical & Medical Instruments & Apparatus

UFPT

Low riskNext report: In 5 days (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 15% in the latest quarter vs a year ago
Profitable every year for 10 years
Sales up 20% last year

Money moves

No insider buying or selling in the last 30 days
Institutions added 8.8% to their holdings in the quarter ending June 2026 (132 bought, 128 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$291.70-1.7% that day

Company value: $2.3B; Share price times all shares
Price vs profit (P/E): 31.4x; You pay about $31 for each $1 of yearly profit
Price vs sales: 3.6x; Company value is 3.6 times a year of sales
Cash vs value: 0%; Cash as a share of company value
Debt vs value: 6%; Debt as a share of company value

From UFPT's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$174.0M+15% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $631.6M, up 7.3% from the 12 months before. Over 5 years, sales grew about 27% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of UFPT. Starting points are the company's recent numbers.

Sales growth+7% a yearRecently: +7.3% a yearProfit margin11%Last 12 months: 11.4%P/E at the end31xToday: 31.4x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$886M

Profit in 5 years$97M

Price these guesses point to$371.08+27% vs $291.70 todayAbout +4.9% a year, before dividends

What today's price needs: with a 11% margin and a 31x P/E, sales would have to grow about 2.0% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

5/7Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.17.8%
PassDebt under half of equityNot relying on borrowed money.0.32x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.11.3%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$91.9M
MissShare count not growingNot diluting owners. Falling means buybacks.+1.8% in 3 years
MissGross margin 40%+Pricing power: sells for well above what it costs to make.28.3%

Revenue: $602.8M; +19.5% vs prior year
5-year growth: +27.4%/yr; revenue, per year
Total debt: $135.5M; 0.32x equity
Current ratio: 2.68x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.